Published in Lancet on May 21, 1994
Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 1.82
Medium-size-vessel vasculitis. Pediatr Nephrol (2009) 1.23
Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (2003) 1.05
Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol (1997) 0.98
The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis. Autoimmun Rev (2013) 0.94
Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis (1995) 0.94
Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1. J Virol (2006) 0.91
The pulmonary physician in critical care * illustrative case 3: pulmonary vasculitis. Thorax (2003) 0.88
Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J Virol (1995) 0.87
Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child. Rheumatol Int (2004) 0.85
Human Parvoviruses. Clin Microbiol Rev (2017) 0.84
Parvovirus B19 infection and myofasciitis. Clin Rheumatol (2004) 0.83
Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q. J Virol (2014) 0.83
Genetic and environmental factors in polymyalgia rheumatica. Ann Rheum Dis (1997) 0.83
Polyarteritis nodosa and parvovirus B19. Lancet (1994) 0.83
The role of cellular immunity in systemic vasculitis. Clin Exp Immunol (1995) 0.81
Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions. Case Rep Med (2012) 0.80
Parvovirus b19 associated hepatitis. Hepat Res Treat (2013) 0.79
Infection with Parvovirus B19. Curr Infect Dis Rep (1999) 0.78
Cutaneous polyarteritis nodosa in childhood: a case report and review of the literature. Arthritis (2010) 0.78
High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: report on one case and review of the literature. Clin Rheumatol (2005) 0.78
Parvovirus B19 and chronic arthritis--causal or casual association? Ann Rheum Dis (1995) 0.77
Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatr Nephrol (2005) 0.76
Real time PCR reconfirmed three novel clinical associations of parvovirus B19: Non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis. Indian J Med Res (2015) 0.75
Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa. Auto Immun Highlights (2013) 0.75
Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations. Intractable Rare Dis Res (2016) 0.75
No evidence of parvovirus B19 in tissue samples from patients with polyarteritis nodosa and microscopic polyangiitis as assessed by the polymerase chain reaction. Ann Rheum Dis (2006) 0.75
Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia. Ann Rheum Dis (1998) 0.75
Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders. J Neurol (2006) 0.75
Adult-Onset Henoch-Schonlein Purpura Duodenitis. J Clin Med Res (2017) 0.75
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet (2001) 15.27
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med (1997) 7.12
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
V beta-specific stimulation of human T cells by staphylococcal toxins. Science (1989) 5.34
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 4.19
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis (1998) 3.97
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua. Lancet (1996) 3.34
Immunization for Ebola virus infection. Nat Med (1998) 3.27
Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet (1999) 3.24
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet (2001) 3.21
Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med (1983) 3.17
Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci U S A (1994) 3.09
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest (1994) 2.88
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation (1994) 2.80
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
The revised two-factor Study Process Questionnaire: R-SPQ-2F. Br J Educ Psychol (2001) 2.72
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med (1990) 2.71
Biochemistry of diseases of immunodevelopment. Annu Rev Biochem (1981) 2.67
DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest (1973) 2.66
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med (1997) 2.64
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med (1997) 2.38
Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med (1997) 2.36
Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med (1975) 2.35
Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol (1992) 2.29
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci U S A (2000) 2.26
Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science (1976) 2.17
Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest (1997) 2.10
Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol (1993) 2.09
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet (1987) 2.05
The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments. J Exp Med (1970) 2.05
Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05
Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr (1991) 2.04
Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis (2001) 2.03
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest (1994) 1.98
Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med (1988) 1.97
Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Proc Natl Acad Sci U S A (1998) 1.97
Spotted fever in Brazil: a seroepidemiological study and description of clinical cases in an endemic area in the state of São Paulo. Am J Trop Med Hyg (2001) 1.95
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol (1992) 1.95
Information collected during the residency match process does not predict clinical performance. Arch Pediatr Adolesc Med (2000) 1.94
Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells. Nat Med (1999) 1.93
Polyclonal activation of human lymphocytes in vitro. I. Characterization of the lymphocyte response to a T cell-independent B cell mitogen. J Immunol (1980) 1.92
Onset and persistence of childhood asthma: predictors from infancy. Pediatrics (2001) 1.91
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol (1998) 1.87
Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest (1996) 1.86
Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81
Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun (2001) 1.80
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol (1998) 1.77
Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin Immunol Immunopathol (1997) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
Transmembrane ion fluxes during activation of human T lymphocytes: role of Ca2+, Na+/H+ exchange and phospholipid turnover. Immunol Rev (1987) 1.74
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
In vivo effects of glucocorticoids on IgE production. J Allergy Clin Immunol (1994) 1.70
Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy (2010) 1.70
Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg (1999) 1.69
Responses of lymphocytes to anisotonic media: volume-regulating behavior. Am J Physiol (1984) 1.69
Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis (1997) 1.69
An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg (1997) 1.68
Chronic rotavirus infection in immunodeficiency. J Pediatr (1980) 1.66
Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol (1991) 1.65
Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am J Respir Cell Mol Biol (1999) 1.64
Induction and separation of antigen-dependent T helper and T suppressor cells in man. Nature (1978) 1.64
Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med (1997) 1.62
Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol (1999) 1.62
Antigen retention in joint tissues in antigen-induced synovitis. Clin Exp Immunol (1974) 1.61
Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med (2001) 1.61
Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness--a murine model. Allergy (1999) 1.60
Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med (1997) 1.60
Production of IgE-potentiating factor in man by T cell lines bearing Fc receptors for IgE. Eur J Immunol (1984) 1.59
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med (1997) 1.58
Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis (1997) 1.56
Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol (2000) 1.56
The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest (1999) 1.56
Hantavirus transmission in the United States. Emerg Infect Dis (1997) 1.55
Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J (1997) 1.53
Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol (1996) 1.52
Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol (1994) 1.52
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med (1985) 1.52
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51